Skip to main content
Caplight Logo









GenieBiome Limited

GenieBiome Limited

Private
Hong KongHealthcare & Life Scienceshttps://geniebiome.com/

Last Round

Series B

Nov 1, 2021

Momentum

Top 50%

of companies Caplight tracks

Company Overview

GenieBiome Limited is a biotechnology company that develops microbiome-based diagnostics and personalized therapeutic solutions for various diseases.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Precision Medicine, D2C Brands, Healthcare Analytics

Business Model

B2C

Customer Profile

Hardware Sales, Services & Consulting

AI Layer

Application

Keywords

microbiome diagnosticsprecision medicinegut microbiomegut health supplementsmetagenomicsbioinformaticscolorectal cancer screeningmicrobiome testingd2c healthprobioticsnon-invasive diagnosticspersonalized nutritionbiotechclinical researchbiohacking

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

GenieBiome Limited Comparables

Compare GenieBiome Limited with similar companies based on industry and business-model similarity.

GenieBiome Limited comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
AMILI
82%
Leucine Rich Bio
79%
Floré
78%

GenieBiome Limited Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series BNov 1, 2021
Series AAug 1, 2020

Key People

Founding team and executive leadership

Rachel Fan

Chief Executive Officer, GenieBiome Limited

Executive Team

GenieBiome Limited Investors

Notable investors and investment history

GenieBiome Limited investors
InvestorRounds
Beyond VenturesSeries A
The Chinese University of Hong KongSeries A

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jun 20, 2026

    Monthly visitors increased 179% MoM, reaching 2.2K.

  • May 15, 2026

    Monthly visitors grew 1234% MoM, from 59 to 787.

GenieBiome Limited Filings

Explore SEC and related filing metadata, where available.

GenieBiome Limited filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about GenieBiome Limited's valuation, stock price, and market status.

Is GenieBiome Limited a public or private company?

GenieBiome Limited is a private company.

What is the current stock price of GenieBiome Limited?

GenieBiome Limited is a private company with no public stock price. No recent secondary market data is available.

How much is GenieBiome Limited worth (valuation)?

Valuation information for GenieBiome Limited is not publicly available.

Can I buy GenieBiome Limited stock?

GenieBiome Limited shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was GenieBiome Limited's last funding round?

GenieBiome Limited's most recent funding round was Series B on November 1, 2021.

Who are the main investors in GenieBiome Limited?

Key investors in GenieBiome Limited include Beyond Ventures, The Chinese University of Hong Kong.

Will GenieBiome Limited IPO soon?

No public IPO plans have been announced for GenieBiome Limited.

How can I track GenieBiome Limited secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor GenieBiome Limited's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersHong Kong
Employee Range15
Year Founded2020
Last FundingNov 1, 2021

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?